CoChat

Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease

Open access
Leake, A, Morris, C.M, Whateley, J · 2000 · Neuroscience Letters

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Several lines of evidence indicate that there may be an inflammatory component to the pathology of Alzheimer's disease (AD), the major form of degenerative dementia in the elderly. Activity of inflammatory cells, and the elaboration of toxic molecules by such cells may be a significant factor in disease progression. In peripheral inflammatory states, the increased activity of matrix metalloproteinase (MMP) enzymes are a major cause of tissue breakdown and secondary damage in diseases such as rheumatoid arthritis. The activity of such enzymes in the normal or diseased central nervous system is, however, not well characterized. We have therefore determined the levels of MMP 1 (collagenase) in the normal human brain and in AD. MMP1 levels were relatively low though were significantly elevated by approximately 50% in AD in all cortical areas examined. Given the activity towards collagen of MMP1, it is possible that enhanced MMP1 activity in AD, may contribute to the blood-brain barrier dysfunction seen in AD.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0304-3940(00)01418-x

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Research works printed but not linked: 1

  1. Cross, 1999, Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro, Glia, 28, 183, 10.1002/(SICI)1098-1136(199912)28:3<183::AID-GLIA2>3.0.CO;2-3 · DOI · Paper page

Cited by

See all 96

Metadata

Authors
Leake, A., Morris, C. M., & Whateley, J.
Corresponding author
Morris, C.M
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2000-09
Volume
291
Issue
3
Pages
201-203
ISSN
0304-3940 (ISSN-L)
OpenAlex
W1969381238
Cited by
95
References
20
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 4 · 2017: 4 · 2016: 4 · 2015: 2 · 2014: 2 · 2013: 10 · 2012: 2
FWCI
2.05
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Neuroscience Letters (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, MMP-1, collagenase, brain, neuroinflammation, blood-brain barrier dysfunction, cortical tissue, collagen degradation, dementia
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Brain, Brain Chemistry, Enzyme-Linked Immunosorbent Assay, Frontal Lobe, Humans, Occipital Lobe, Parietal Lobe, Temporal Lobe, Matrix Metalloproteinase 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease. https://app.cochat.ai/papers/10.1016/s0304-3940(00)01418-x
The paper
Leake, A., Morris, C. M., & Whateley, J. (2000). Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease. Neuroscience Letters. https://doi.org/10.1016/s0304-3940(00)01418-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.